NCT07123129 2026-01-30
A Trial of SHR-7782 for Treatment of Advanced Malignant Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1 Recruiting
Clinical Trials
6 trialsNCT03875157 2023-02-27
Study of IBI318 in Participants With Advanced Malignancies
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Completed
NCT02978482 2021-08-18
A Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced Malignancies
AstraZeneca
Phase 1 Completed
NCT04216082 2020-01-02
A Study of Anlotinib in Subjects With Advanced Malignancy
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2 Completed
NCT01945164 2014-10-21
XL999 Administered Intravenously to a Subject With Advanced Malignancies
The University of Texas Health Science Center at San Antonio
No longer available
NCT00978926 2010-04-09
A Study of the Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced Malignancies
National University Hospital, Singapore
Completed